CTRI/2018/05/014111尚未招募2 期
Evaluation of safety and therapeutic efficacy of a siddha herbomineral formulation KANDAAMALAGA ILAKAM (Internal) in the treatment of AZHAL VELUPPU NOI (Iron deficiency anaemia) - KANDAAMALAGA ILAKAM
Ayothidoss Pandithar Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Hb level less than normal range, For male:7-10gms/dl(normal:13-18gms/dl),For female:7-10gms/dl(normal:11.5-16.5), patient willing to undergo blood investigation, patient who are willing to participate in study and signing in informed consent form.
排除标准
- •Hypertention, presence of any associated severe systemic illness (Eg.cancer, rheumatoid), Endocrine disorder( thyroid abnormality, diabetes mellitus), severe cardiac disease,Inherited defects(sickle cell Anemia, Thalassemia, Aplastic anaemia), patient not willing to give blood sample
研究者
相似试验
已完成
2 期
A study on siddha medicine kumaara veeriya kaantha chenduram for anaemiaCTRI/2019/04/018795Ayothidoss Pandithar hospital30
已完成
4 期
Evaluation of therapeutic efficacy and safety of artesunate-amodiaquine, artemether-lumefantrine and dihydroartemisinine-piperaquine for the treatment of uncomplicated Plasmodium falciparum in Democratic Republic of CongoInfection - Studies of infection and infectious agentsMalariaACTRN12616001423404Ministry of Health534
进行中（未招募）
1 期
Study of the safety and effectiveness of drug AZD4017 at reducing pressure in the brain, in idiopathic intracranial hypertension.MedDRA version: 18.0Level: PTClassification code 10004277Term: Benign intracranial hypertensionSystem Organ Class: 10029205 - Nervous system disordersIdiopathic Intracranial HypertensionEUCTR2013-003643-31-GBniversity of Birmingham30
招募中
1 期
Itolizumab (T1h) combined with insulin in patients with Type I Diabetes MellitusDiabetes Mellitus, Type 1Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System DiseasesDiabetes MellitusType 1 diabetes mellitusRPCEC00000225Center of Molecular Immunology (CIM)40
尚未招募
2 期
VALERGEN-combination of routes- Asthma-Adults-Phase IIAsthmaBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System DiseasesEnvironmental IllnessRPCEC00000298ational Center of Bioproducts (BioCen)180